Tubercular involvement of pancreas is rare. It presents as a focal lesion of pancreas on cross sectional imaging. Endosonography with fine-needle aspiration (EUS-FNA) is important for a effectively timed presurgical evaluation.
A retrospective evaluation was carried out on 117 circumstances of pancreatic focal mass current course of EUS-FNA at our institution over a interval of three years, and 5 circumstances with pancreatic tuberculosis (TB) had been detected.
The medical presentation numerous from obstructive jaundice, recurrent acute pancreatitis to incidentaloma of pancreas. All victims acquired antitubercular treatment and had been adopted up for on the very least 6 months.
In conclusion, pancreatic tuberculosis is a differential of a pancreatic focal lesion and EUS-FNA is the technique for evaluation of this case that can obviate surgical exploration.

Mycobacterium tuberculosis-Explicit T Cell Purposeful, Memory, and Activation Profiles in QuantiFERON-Reverters Are Fixed With Managed An infectioN

Reversion of immune sensitization exams for Mycobacterium tuberculosis (M.tb) an an infection, resembling interferon-gamma launch assays or tuberculin pores and pores and skin test, has been reported in quite a few analysis.
We hypothesized that QuantiFERON-TB Gold (QFT) reversion is said to a decline of M.tb-specific helpful T cell responses, and a particular pattern of T cell and innate responses as compared with persistent QFT+ and QFT- individuals.
We in distinction groups of healthful adolescents (n=~30 each), outlined by 4, 6-monthly QFT exams: reverters (QFT+/+/-/-), non-converters (QFT-/-/-/-) and persistent positives (QFT+/+/+/+).
We stimulated peripheral blood mononuclear cells with M.tb antigens (M.tb lysate; CFP-10/ESAT-6 and EspC/EspF/Rv2348 peptide swimming swimming pools) and measured M.tb-specific adaptive T cell memory, activation, and helpful profiles; along with helpful innate (monocytes, pure killer cells), donor-unrestricted T cells (DURT: γδ T cells, mucosal-associated invariant T and pure killer T-like cells) and B cells by motion cytometry.
Projection to latent home discriminant analysis was utilized to seek out out choices that most interesting distinguished between QFT reverters, non-converters and persistent positives. No longitudinal modifications in immune responses to M.tb had been seen upon QFT reversion.
M.tb-specific Th1 responses detected in reverters had been of intermediate magnitude, bigger than responses in QFT non-converters and reduce than responses in persistent positives.
About one third of reverters had a robust response to CFP-10/ESAT-6. Amongst these with measurable responses, lower proportions of TSCM (CD45RA+CCR7+CD27+) and early differentiated (CD45RA-) IFN-γ-TNF+IL-2- M.tb lysate-specific CD4+ cells had been seen in reverters in distinction with non-converters.
Conversely, bigger proportions of early differentiated and reduce proportions of effector (CD45RA-CCR7-) CFP10/ESAT6-specific Th1 cells had been seen in reverters as compared with persistent-positives. No variations in M.tb-specific innate, DURT or B cell helpful responses had been seen between the groups.
Statistical modelling misclassified the overwhelming majority of reverters as non-converters additional usually than that they had been appropriately categorised as reverters or misclassified as persistent positives.
These findings suggest that QFT reversion occurs in a heterogeneous group of individuals with low M.tb-specific T cell responses. In some individuals QFT reversion may finish end result from assay variability, whereas in others the magnitude and differentiation standing of M.tb-specific Th1 cells are in line with well-controlled M.tb an an infection.
Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India

Disseminated Tuberculosis Associated With Adalimumab Treatment

Therapeutic blockade of tumour necrosis difficulty alpha (anti-TNF-α) is the mainstay remedy of quite a few rheumatologic sicknesses. They’re unfrequently associated to opportunistic infections and latent tuberculosis (TB) screening is paramount sooner than immunosuppression.
A 62-year-old man with psoriatic arthritis was beneath remedy with adalimumab for over 5 years. The screening for latent tuberculosis an an infection (LTBI) earlier to the start of immunosuppression was detrimental, and a subsequent interferon gamma launch assay 4 years later was moreover detrimental.
He launched inside the emergency division complaining of asthenia, anorexia, fever, night sweats and weight discount for over 5 months. He moreover complained of memory loss, no matter his common cognitive and neurological examination.
After an exhaustive workup, he was recognized with a disseminated tuberculosis (cerebral, pulmonary and peritoneal) and dealt with accordingly. TB evaluation stays troublesome in positive situations.
Latent TB screening exams may lack sensitivity and immunosuppressive treatment will improve the hazard of disseminated an an infection. We discuss in regards to the workup and administration of a central nervous system disseminated TB related to adalimumab treatment.
Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India

Distinction-Enhanced Ultrasound Imaging Choices of Focal Splenic Tuberculosis

BACKGROUND The aim of this look at was to characterize the contrast-enhanced ultrasound imaging choices of focal splenic tuberculosis. MATERIAL AND METHODS We retrospectively analyzed the usual ultrasound (US) and contrast-enhanced ultrasound (CEUS) imaging choices of 22 victims with splenic TB confirmed by surgical histopathology or biopsy.
RESULTS Typical US demonstrated that 15 of the 22 victims had a single lesion, whereas 7 had quite a few lesions. The utmost diameter of the lesions ranged from 1.zero to a few.7 cm. Of the 22, 17 had been detected with hypoecho and 5 had been detected with superior echo by typical US. Seven (7/22) had been detected with blood motion alerts by coloration Doppler motion image (CDFI).
CUES demonstrated that 18 circumstances (81.8%, 18/22) began to bolster inside the arterial part, principally adopted by gradual wash-out inside the intermediate or late parenchymal part, and 4 (18.2%, 4/22) launched with non-enhancement all through all phases.
The enhancement patterns had been categorized into 4 kinds: Variety I, homogeneous enhancement (2/22); Variety II, rim-like enhancement (12/22); Variety III, septation-like enhancement (4/22); and Variety IV, non-enhancement (4/22).
CONCLUSIONS CEUS confirmed that splenic TB lesions had been enhanced inside the arterial part, adopted by gradual washed out or persistent enhancement inside the intermediate and late parenchymal phases.
The rim- or septation-like enhancement may be helpful for diagnosing splenic TB. The splenic lesions presenting spherical hypoecho by typical US and full non-enhancement by CEUS are extraordinarily suspicious of splenic TB.

A high-frequency single nucleotide polymorphism inside the MtrB sensor kinase in medical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties

The DNA polymorphisms current in medical strains of Mycobacterium tuberculosis drive altered physiology, virulence, and pathogenesis in them.
Although the lineages of these medical strains might be traced once more to frequent ancestor/s, there exists a plethora of distinction between them, in distinction to individuals who have developed inside the laboratory.
Endoscopic ultrasonographic diagnosis of pancreatic tuberculosis in immunocompetent patients-A case series from eastern India
We decide a mutation present in ~80% of medical strains, which maps inside the HATPase space of the sensor kinase MtrB and alters kinase and phosphatase actions, and impacts its physiological perform.
The modifications conferred by the mutation had been probed by in-vitro biochemical assays which revealed modifications in signaling properties of the sensor kinase. These modifications moreover impact bacterial cell division costs, measurement and membrane properties.

Cancer Antigen 50 Antigen
VAng-Cr3877-50kU 50 kU
EUR 6642
Description: Cancer Antigen 50 Antigen, Host/Source: Human Cell Culture. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

A549 HCP Control Antigen
F237 50 ul
EUR 308.4
Description: A549 HCP Control Antigen by Cygnus Technologies is available in Europe via Gentaur.

Cancer Antigen 72-4 Antigen
VAng-Cr3878-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 72-4 Antigen, Host/Source: Metastatic Liver. The purity is ~65% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Antigen 85-A Antibody (HRP)
20-abx109227
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A Antibody (FITC)
20-abx107809
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Antigen 85-A (Ag85A) Antibody
20-abx110661
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

A549 HCP Antigen Concentrate
F233G 200 ul
EUR 540
Description: A549 HCP Antigen Concentrate by Cygnus Technologies is available in Europe via Gentaur.

Antigen 85-A Antibody (Biotin)
20-abx106397
  • EUR 493.20
  • EUR 2214.00
  • EUR 718.80
  • EUR 218.40
  • EUR 360.00
  • 100 ug
  • 1 mg
  • 200 ug
  • 20 ug
  • 50 ug

Cancer Antigen 125 Antigen (Ascites Fluid)
VAng-Cr3870-10kU 10 kU
EUR 1132.8
Description: Cancer Antigen 125 Antigen, Host/Source: Ascites Fluid. The purity is ≥ 95% by SDS-PAGE.

Cancer Antigen 125 Antigen (Human Adenocarcinoma)
VAng-Cr3868-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is detected by salt extraction and chromatography.

Human carcinoembryonic antigen (CEA) antigen
CEA15-N-100 100 ug
EUR 270

HCV NS4 1916-1947aa recombinant antigen
00156-V-01mg 0,1 mg
EUR 321
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS4 1916-1947aa recombinant antigen
00156-V-1000ug 1000 ug
EUR 1539
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen
00157-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen
00157-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2061-2302aa recombinant antigen.

HCV NS5 2212-2313aa recombinant antigen
00158-V-01mg 0,1 mg
EUR 321
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

HCV NS5 2212-2313aa recombinant antigen
00158-V-1000ug 1000 ug
EUR 1539
Description: HCV NS5 2212-2313aa recombinant antigen. Available genotypes: 1a, 1b, 2a, 2b, 3a, 3b, 4, 5, 6a.

HCV NS4 1916-1947aa recombinant antigen.
00156-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS4 1916-1947aa recombinant antigen.

HCV NS5 2061-2302aa recombinant antigen.
00157-V-100ugvial 100 ug/vial
EUR 150
Description: HCV NS5 2061-2302aa recombinant antigen.

Cancer Antigen CEA Antigen (Human Fluids)
VAng-Wyb8644-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Calibrator Grade, Cancer antigen from Human Fluids, 1.13 mg/mL.

Cancer Antigen 19-9 Antigen (Liver Carcinoma)
VAng-Cr3873-10kU 10 kU
EUR 472.8
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is detected by gel filtration and ion-exchange chromatography. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

HCV core 2-119aa recombinant antigen
00150-V-01mg 0,1 mg
EUR 321
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

HCV core 2-119aa recombinant antigen
00150-V-1000ug 1000 ug
EUR 1539
Description: HCV core 2-119aa recombinant antigen. Genotypes available: 1a, 1b, 2a, 2b, 3a, 3b, 3/10, 4, 5, 6a

Prostate Specific Antigen Std Grade Antigen
VAng-Cr3891-1mg 1 mg
EUR 604.8
Description: Prostate Specific Antigen Std Grade Antigen, Host/Source: Human Seminal Fluid. The purity is detected by salt precipitation.

Cancer Antigen 125 Antigen (Human Adenocarcinoma) (> 90%)
VAng-Cr3869-25kU 25 kU
EUR 967.2
Description: Cancer Antigen 125 Antigen, Host/Source: Human Adenocarcinoma. The purity is> 90% by SDS-PAGE. Matched Pair: HM183, HM184, HM185, HM186.

M. Tuberculosis 85-A Antigen
DAGA-181 100 µg
EUR 868.8

HBV surface recombinant antigen HBsAg antigen
00123-V-01mg 0,1 mg
EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen
00123-V-1000ug 1000 ug
EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 22 kDa Pichia pastoris recombinant High purity

HBV surface recombinant antigen HBsAg antigen
00124-V-01mg 0,1 mg
EUR 321
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

HBV surface recombinant antigen HBsAg antigen
00124-V-1000ug 1000 ug
EUR 1539
Description: HBV surface recombinant antigen HBsAg antigen 31 kDa E. coli recombinant

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (> 90%)
VAng-Cr3875-25kU 25 kU
EUR 885.6
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma. The purity is> 90% by SDS-PAGE. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Cancer Antigen AFP Antigen (Human Cord Blood)
VAng-Wyb8624-inquire inquire Ask for price
Description: Alpha Fetoprotein (66 kDa), Cancer antigen from Human Cord Blood, 1.73 mg/mL.

Cancer Antigen CA-125 Antigen (Human Fluids)
VAng-Wyb8639-inquire inquire Ask for price
Description: CA-125, Calibrator Grade, cancer antigen from Human Fluids, 53.26 KU/mL.

Cancer Antigen 15-3 MUC 1 Antigen (Human Milk)
VAng-Cr3871-10kU 10 kU
EUR 505.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Milk. The purity is detected by salt extraction and delipidization following high speed centrifugation. It is tested negative for HBsAg, antibodies to HCV and HIV 1/2.

Sperm Associated Antigen 11A (SPAG11A) Antibody
abx238139-100ug 100 ug
EUR 661.2

Sperm Associated Antigen 11A (SPAG11A) Antibody
20-abx115757
  • EUR 878.40
  • EUR 477.60
  • 150 ul
  • 50 ul

Sperm Associated Antigen 11A (SPAG11A) Antibody
abx025940-400ul 400 ul
EUR 627.6

Sperm Associated Antigen 11A (SPAG11A) Antibody
abx025940-80l 80 µl
EUR 343.2

Sperm Associated Antigen 11A (SPAG11A) Antibody
20-abx124930
  • EUR 493.20
  • EUR 710.40
  • 100 ul
  • 200 ul

MPO Antigen
E61A00501 1mg
EUR 1230

HAV Antigen
E61H00101 1mg
EUR 733.2

HBS Antigen
E61H00301 1mg
EUR 374.4

HBS Antigen
E61H00302 1mg
EUR 374.4

HBe Antigen
E61H00501 1mg
EUR 463.2

HBc Antigen
E61H00701 1mg
EUR 463.2

AFP Antigen
E62C002 20ug
EUR 458.4

HCG Antigen
E62C004 100ug
EUR 458.4

CEA Antigen
E62C010 20ug
EUR 458.4

CK8 Antigen
E62C02001 20ug
EUR 458.4

CRP Antigen
E64C00501 1mg
EUR 840

CRP Antigen
E64C00502 1mg
EUR 840

CD9 Antigen
E6TA00101 0.1mg
EUR 411.6

BSA Antigen
IM112 1 ml
EUR 342
Description: BSA Antigen by Cygnus Technologies is available in Europe via Gentaur.

HSA Antigen
IM118 1 ml
EUR 342
Description: HSA Antigen by Cygnus Technologies is available in Europe via Gentaur.

CDV Antigen
VAng-Lsx0016-1mg 1 mg
EUR 1688.4
Description: Canine Distemper Virus Antigen from SL-29 cells.

Gastrointestinal Cancer Antigen (CA 19-9), antigen grade
CA1991-N-10 10 KU
EUR 634.8

Inactivated Coxsackievirus A16 Antigen
VAng-Lsx0079-1mL 1 mL
EUR 700.8
Description: Coxsackievirus A16, natural antigen.

S100 Antigen
E62B003 20ug
EUR 458.4

CA50 Antigen
E62C009 10KU
EUR 458.4

CK18 Antigen
E62C02101 20ug
EUR 458.4

CK20 Antigen
E62C02201 20ug
EUR 458.4

GP73 antigen
E62C02701 20ug
EUR 458.4

TP17 Antigen
E62H00701 100ug
EUR 458.4

TP47 Antigen
E62H00702 100ug
EUR 458.4

cTnI antigen
E64C00101 100ug
EUR 508.8

cTnI antigen
E64C00102 100ug
EUR 733.2

cTnC antigen
E64C01301a 20ug
EUR 411.6

sST2 antigen
E64C01501 20ug
EUR 411.6

PAPP Antigen
E64D00101 100ug
EUR 1425.6

PAPP Antigen
E64D00102 1mg
EUR 5910

CD63 Antigen
E6TA00102 0.1mg
EUR 411.6

CD81 Antigen
E6TA00103 0.1mg
EUR 411.6

Cancer Antigen CEA Antigen (Human Metastatic Liver)
VAng-Wyb8645-inquire inquire Ask for price
Description: Carcinoembryonic Antigen, Antigen Grade, Cancer antigen from Human Metastatic Liver, 5.5 mg/mL.

CA242 Antigen
E62C00601 50KU
EUR 2078.4

CA242 Antigen
E62C00602 10KU
EUR 458.4

CA199 Antigen
E62C007 10KU
EUR 458.4

CA199 Antigen
E62C00701 50KU
EUR 1180.8

CA199 Antigen
E62C00702 50KU
EUR 1620

CA125 Antigen
E62C011 10KU
EUR 458.4

CA153 Antigen
E62C012 10KU
EUR 458.4

EpCAM Antigen
E64B00107 0.1mg
EUR 411.6

HSP70 Antigen
E6TA00104 0.1mg
EUR 411.6

CD133 Antigen
E6TA00105 0.1mg
EUR 411.6

CD32a Antigen
E6TA00106 0.1mg
EUR 411.6

Cancer Antigen CA-125 Antigen (Human Adenocarcinoma)
VAng-Wyb8642-inquire inquire Ask for price
Description: CA-125, Calibrator Grade, Cancer antigen from Human Adenocarcinoma, 500 kIU / mL.

S100BB Antigen
E62B00201 20ug
EUR 458.4

S100BB Antigen
E62B00202 20ug
EUR 458.4

Giardia Trophozoite Recombinant antigen antigen 34 kDa
00321-V-01mg 0,1 mg
EUR 321
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280

Giardia Trophozoite Recombinant antigen antigen 34 kDa
00321-V-1000ug 1000 ug
EUR 1539
Description: Giardia Trophozoite Recombinant antigen antigen 34 kDa a.a. 21-280

Cancer Antigen 19-9 Antigen (Liver Carcinoma) (High purity)
VAng-Cr3874-25kU 25 kU
EUR 1033.2
Description: Cancer Antigen 19-9 Antigen, Host/Source: Liver Carcinoma.

S100A1B Antigen
E62B00101 20ug
EUR 458.4

S100A1B Antigen
E62B00102 20ug
EUR 458.4

Insulin Antigen
E64I001 1mg
EUR 418.8

Insulin Antigen
IM121 1 ml
EUR 342
Description: Insulin Antigen by Cygnus Technologies is available in Europe via Gentaur.

Ferritin Antigen
E62C013 100ug
EUR 458.4

Ferritin Antigen
E62C01304 100ug
EUR 458.4

Copeptin antigen
E64C01601 100ug
EUR 411.6

Cancer Antigen AFP Antigen (Human hepatocellular carcinoma)
VAng-Wyb8625-inquire inquire Ask for price
Description: Alpha Fetoprotein, Antigen Grade, Cancer antigen from human hepatocellular carcinoma, 2.93 mg/mL.

HHV-4 recombinant EA antigen. Region: 306-390aa
00213-V-100ugvial 100ug/vial
EUR 150
Description: HHV-4 recombinant EA antigen. Region: 306-390aa

Rotavirus Antigen
DAGA-258 1 ml dry ice
EUR 873.6

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit
E02C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit
E02C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Rat Cancer/testis antigen 47A(CT47A1) ELISA kit
E02C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Rat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit
E07C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit
E07C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit
E08C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit
E08C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Dog Cancer/testis antigen 47A(CT47A1) ELISA kit
E08C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Canine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Pig Cancer/testis antigen 47A(CT47A1) ELISA kit
E07C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Porcine Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Cancer Antigen 15-3 MUC 1 Antigen (Human Ascites Fluid)
VAng-Cr3872-10kU 10 kU
EUR 1363.2
Description: Cancer Antigen 15-3 MUC 1 Antigen, Host/Source: Human Ascites Fluid.

GPA33 Antibody / Cell surface A33 antigen
F55008-0.08ML 0.08 ml
EUR 140.25
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling.

GPA33 Antibody / Cell surface A33 antigen
F55008-0.4ML 0.4 ml
EUR 322.15
Description: GPA33 is a cell surface antigen that is expressed in greater than 95% of human colon cancers. It may play a role in cell-cell recognition and signaling.

HHV-4 recombinant p18 antigen Region: 1-119aa
00211-V-100ugvial 100ug/vial
EUR 150
Description: HHV-4 recombinant p18 antigen Region: 1-119aa

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit
E06C2138-192T 192 tests
EUR 1524
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit
E06C2138-48 1 plate of 48 wells
EUR 624
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Goat Cancer/testis antigen 47A(CT47A1) ELISA kit
E06C2138-96 1 plate of 96 wells
EUR 822
Description: A sandwich ELISA for quantitative measurement of Goat Cancer/testis antigen 47A(CT47A1) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC800883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC800883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC810883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC810883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF680R conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC940883-100 100uL
EUR 238.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL

PSA (Prostate Specific Antigen)(A67-B/E3) Antibody
BNC940883-500 500uL
EUR 652.8
Description: Primary antibody against PSA (Prostate Specific Antigen)(A67-B/E3), CF594 conjugate, Concentration: 0.1mg/mL
The look at highlights the have an effect on of DNA polymorphisms on the pathophysiology of medical strains and provides insights into underlying mechanisms that drive signal transduction in pathogenic micro organism.

RELATED ARTICLESMORE FROM AUTHOR

LEAVE A REPLY

Please enter your comment!
Please enter your name here